Biotechnology Assets, S.A. (BME:BST)
Spain · Delayed Price · Currency is EUR 0.2360
+0.0120 (5.36%)
Mar 18, 2026, 5:35 PM CET
Biotechnology Assets Market Cap
Biotechnology Assets has a market cap or net worth of €17.53 million as of March 18, 2026. Its market cap has decreased by -26.29% in one year.
Market Cap
17.53M
Enterprise Value
19.10M
Revenue
3.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.24
Market Cap Chart
Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 17.53M, a decrease of -76.52%. That is a compound annual growth rate of -16.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 17.53M | 22.84% |
| Dec 31, 2025 | 14.27M | -21.93% |
| Dec 31, 2024 | 18.28M | -20.03% |
| Dec 29, 2023 | 22.86M | 84.02% |
| Dec 30, 2022 | 12.42M | -40.67% |
| Dec 30, 2021 | 20.94M | -3.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.71B |
| Laboratorios Farmaceuticos Rovi | 4.09B |
| Almirall | 2.46B |
| Pharma Mar | 1.50B |
| Oryzon Genomics | 221.69M |
| Atrys Health | 220.04M |
| Prim, S.A. | 217.80M |
| Laboratorio Reig Jofre | 191.32M |